Navigation Links
Medical Breakthrough ... Doctor Discovers 'Penetrating Carrier' That Eradicates Fungus
Date:11/7/2007

Innovative Custom Products, Inc., has obtained exclusive distribution rights to a 'first of its kind' product line, CureCeuticals, invented by Dr. Marc Selner, a nationally renowned Sports Podiatrist; Cure Toenail

Fungus and Cure Athlete's Foot.

MILWAUKEE, Nov. 7 /PRNewswire/ -- Joe Williams, President and Founder of Innovative Custom Products, Inc., announced today that his firm obtained exclusive distribution rights to a "first of its kind" product line, CureCeuticals, invented by Dr. Marc Selner, a nationally renowned Sports Podiatrist. The lead products in the CureCeuticals line are Cure Toenail Fungus and Cure Athlete's Foot. Both products are all-natural, all-organic, allopathic and homeopathic formulations. These cutting edge products are available without prescription and come in a convenient travel size. Williams said a full Skin Care line utilizing Dr. Selner's breakthrough "penetrating carrier technology" is in development and will be ready for distribution under the CureCeuticals brand within the next 12-18 months.

According to Dr. Selner, Cure Toenail Fungus is the only patent pending OTC topical that actually penetrates the nail, kills the fungus, and allows growth of a new, healthy nail. Cure Athlete's Foot unique formulation allows it to work on contact and eliminates most Athlete's Foot, Jock Itch, and Ringworm within 48 hours. Cure Athlete's Foot also relieves the itching, burning, and scaling associated with these conditions immediately upon application. These products have been used for years in doctors' offices to successfully treat and remedy toenail fungus (Onychomycosis) and athlete's foot (Tenia Pedis), respectively, without side effects.

Dr. Selner said that, unlike other products, Cure Toenail Fungus and Cure Athlete's Foot utilize his "Penetrating Carrier Technology" to allow the contained anti-fungal compounds to actually penetrate the nail or the skin and go directly to where the fungus resides and other topicals do not reach. This delivery system is a major breakthrough; no other OTC product even claim to penetrate the nail and reach the nail bed. The only competitive product is a prescription drug that requires doctor visits and blood tests every six weeks because of its known side effects, and could cost as much as $1,400 for comparable results.

Innovative Custom Products, Inc., a Wisconsin corporation in business since 1992, is a manufacturer and distributor of consumer and pharmaceutical products. According to Williams, consumers are driving the demand for organic products and big box retailers are now paying attention. Williams believes the CureCeuticals product line will generate over $20 million in sales within the next couple years. These products are currently sold in independent pharmacies throughout the USA and are expected in national drug chains soon. Negotiations are currently in place to open the European markets and Williams hopes to open the Canadian and Caribbean markets in 2008. To contact Investor Relations or Distribution Services, email us at: contact@icpCorporation.com or telephone us at (414) 358-1802.

To contact Investor Relations or Distribution Services, email us at: contact@icpCorporation.com or telephone us at (414) 358-1802.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Innovative Custom Products, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... just published their findings on what they believe could be a new and ... of the new research. Click here to read it now. , ...
(Date:6/27/2016)... N.C. (PRWEB) , ... June 27, 2016 , ... ... commercial operations for Amgen, will join the faculty of the University of ... as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):